Myozyme Side Effects
|
|
Patientsville.com is the most complete Drug Side Effects Resource on the Internet. View over 1 million side effect patient episodes and learn about side effect symptoms and remedies. Connect with others who had similar side effects. Help Community by Submitting Your Side Effect.
Recently reported Myozyme Side Effects
Did You Have Myozyme Side Effect? |
Myozyme Side Effects Poll Results |
|
Vote Below:
|
|
Myozyme Comments and Questions
Join the discussion:
No comments have been provided.
Ask Community about Myozyme:
What is Your Question? Ask Community:
Daily Health Videos
Myozyme Side Effects reported on Patientsville.com
None reported at this time.Myozyme Side Effects reported to FDA
Showing 1-50 of 689 Next >
Myozyme Side Effects Report #5201369-0Pharmacist from UNITED STATES reported Myozyme side effect on Dec 18, 2006. Male patient, child 11 years of age, weighting 69.45 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: appendicitis
, dehydration. Myozyme dosage: 630 MG Q2WKS IV. Patient was hospitalized. Patient recovered.
Myozyme Side Effects Report #5201827-9
Myozyme side effect was reported by a Physician from HUNGARY on Dec 21, 2006. Female patient, 43 years of age, weighting 114.6 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: abdominal distension, dizziness
, dyspnoea, fall , fatigue, hyperhidrosis, hypertension, muscular weakness, pallor. Myozyme dosage: 20 MG/KG Q2WKS IV. During the same period patient was treated with SUPRASTIN. Patient recovered.Myozyme Side Effects Report #5203378-4
Physician from GREECE reported Myozyme side effect on Dec 22, 2006. Female patient, weighting 17.64 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: abdominal infection, alanine aminotransferase increased, aspartate aminotransferase increased, cardiac disorder, cardiac index increased, cardio-respiratory arrest, diarrhoea, lower respiratory tract infection. Myozyme dosage: 20 MG/KG Q2WKS IV. During the same period patient was treated with ALPHA, HCL THIAZIDE, SPIRONOLACTONE, DIGITALIS, ENALAPRIL MALEATE. Patient was hospitalized. Patient died on 12/29/2006.
Myozyme Side Effects Report #5209130-8
Myozyme side effect was reported by a Physician from BRAZIL on Dec 28, 2006. Female patient, weighting 20.06 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: areflexia, atelectasis, blood calcium increased, blood glucose increased, blood lactic acid increased, blood potassium decreased, cardiac failure, cardio-respiratory arrest. Myozyme dosage: 20 MG/KG Q2WKS IV. During the same period patient was treated with ALPHA. Patient recovered.
Myozyme Side Effects Report #5209170-9
Physician from UNITED STATES reported Myozyme side effect on Dec 28, 2006. Male patient, weighting 12.13 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: asthenia, blood creatine phosphokinase increased, blood culture positive, candidiasis, central line infection, condition aggravated, enterococcal infection, feeding disorder, hyporeflexia. Myozyme dosage: 20 MG/KG Q2WKS IV. During the same period patient was treated with BUDESONIDE, XOPENEX, LANSOPRAZOLE, DIGOXIN, PROPRANOLOL, AMIODARONE. Patient was hospitalized. Patient recovered.
Myozyme Side Effects Report #5211742-2
Myozyme side effect was reported by a Physician from HUNGARY on Dec 30, 2006. Female patient, 43 years of age, weighting 114.6 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: abdominal distension, anaphylactic reaction, chest pain
, dizziness , dyspnoea, hyperhidrosis, hypertension, muscular weakness. Myozyme dosage: 20 MG/KG Q2WKS IV. During the same period patient was treated with SUPRASTIN, TELFAST, CALCIUM, CALCIUM GLUCOMATE. Patient recovered.Myozyme Side Effects Report #5216598-X
Consumer or non-health professional from CANADA reported Myozyme side effect on Jan 04, 2007. Male patient, 15 years of age, weighting 96.12 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: accident, muscular weakness, pneumonia
, scoliosis, therapeutic response decreased, wrist fracture. Myozyme dosage: 20 MG/KG Q2WKS IV. During the same period patient was treated with ALPHA, PAMIDRONATE DI, CALCIUM. Patient recovered.Myozyme Side Effects Report #5216726-6
Myozyme side effect was reported by a Physician from GREECE on Jan 04, 2007. Female patient, weighting 17.64 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: abdominal infection, acute respiratory failure, alanine aminotransferase increased, antibody test positive, asthenia, cardiac failure, cardiac failure acute, cardiac index increased, cardiopulmonary failure. Myozyme dosage: 20 MG/KG QWK IV. During the same period patient was treated with ALPHA, HCL THIAZIDE, SPIRONOLACTONE, DIGITALIS, ENALAPRIL MALEATE. Patient was hospitalized. Patient died on 12/29/2006.
Myozyme Side Effects Report #5216727-8
Consumer or non-health professional from FRANCE reported Myozyme side effect on Jan 04, 2007. Female patient, 45 years of age, weighting 123.5 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: anaphylactic reaction, back pain
, blood pressure decreased, chest discomfort, chest pain , erythema, flushing, infusion related reaction, nausea . Myozyme dosage: unknown. During the same period patient was treated with FERROUS SULPHATE, POLARAMINE, TELFAST. Patient was hospitalized. Patient recovered.Myozyme Side Effects Report #5218521-0
Myozyme side effect was reported by a Physician from TURKEY on Jan 08, 2007. Male patient, child 3 years of age, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: lung infection. Myozyme dosage: unknown. During the same period patient was treated with ALPHA. Patient died on 12/05/2005.
Myozyme Side Effects Report #5218783-X
Health Professional from UNITED STATES reported Myozyme side effect on Jan 09, 2007. Male patient, weighting 11.05 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: glycogen storage disease type ii, hypotonia, muscular weakness, oral intake reduced, pneumonia
, respiratory distress, sleep apnoea syndrome, stomatitis. Myozyme dosage: 130 MG Q2WKS IV. During the same period patient was treated with ALBUTEROL, PROPRANOLOL, ZANTAC. Patient was hospitalized. Patient recovered.Myozyme Side Effects Report #5218784-1
Myozyme side effect was reported by a Physician from UNITED STATES on Jan 09, 2007. Male patient, weighting 12.13 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: asthenia, blepharospasm, blood creatine phosphokinase increased, blood culture positive, candidiasis, cardiac disorder, central line infection, endotracheal intubation complication, enterococcal infection. Myozyme dosage: 20 MG/KG Q2WKS IV. During the same period patient was treated with BUDESONIDE, XOPENEX, LANSOPRAZOLE, DIGOXIN, PROPRANOLOL, AMIODARONE. Patient was hospitalized. Patient recovered.
Myozyme Side Effects Report #5224549-7
Health Professional from UNITED STATES reported Myozyme side effect on Jan 12, 2007. Female patient, weighting 26.01 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: cardiac disorder, urticaria. Myozyme dosage: 250 MG Q2WKS IV. During the same period patient was treated with PULMICORT, CAPTOPRIL, CARVEDILOL, DIGOXIN, LASIX. Patient recovered.
Myozyme Side Effects Report #5226048-5
Myozyme side effect was reported by a Physician from BRAZIL on Jan 15, 2007. Female patient, weighting 14.00 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: aspiration, bradycardia, choking
, cough, dysphagia, fatigue, haematocrit decreased, heart rate decreased, hypotension. Myozyme dosage: 20 MG/KG IV. During the same period patient was treated with PROPRANOLOL, FERROUS SULPHATE, HYDROCORTISONE, HYDROXYZINE. Patient was hospitalized. Patient recovered.Myozyme Side Effects Report #5226776-1
Physician from NETHERLANDS reported Myozyme side effect on Jan 15, 2007. Female patient, child 8 years of age, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: abdominal pain upper, bradycardia, bronchospasm, cardiac arrest
, gastroenteritis , infusion related reaction, oedema. Myozyme dosage: unknown. During the same period patient was treated with ZYRTEC, HYDROCORTISONE. Patient was hospitalized. Patient recovered.Myozyme Side Effects Report #5226777-3
Myozyme side effect was reported by a Physician from GERMANY on Jan 16, 2007. Male patient, 40 years of age, weighting 224.9 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: deep vein thrombosis
. Myozyme dosage: unknown. During the same period patient was treated with LISINOPRIL, NEBILET, PHYSIOTENS, INSULIN. Patient was hospitalized. Patient recovered.Myozyme Side Effects Report #5229469-X
Physician from UNITED STATES reported Myozyme side effect on Jan 17, 2007. Male patient, weighting 15.21 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: blood pressure systolic increased, cardiac arrest
, infection , pyrexia, respiratory distress, tachycardia, wheezing. Myozyme dosage: 20 MG/KG Q2WKS IV. During the same period patient was treated with DIPHENHYDRAMINE, ACETAMINOPHEN, POTASSIUM CHLORIDE, FAMOTIDINE, DIGOXIN, PROPRANOLOL, FUROSEMIDE, HYDROCHLOROTHIAZIDE. Patient recovered.Myozyme Side Effects Report #5285750-X
Myozyme side effect was reported by a Physician from UNITED STATES on Oct 02, 2006. Female patient, 30 years of age, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: sinus tachycardia. Myozyme dosage: unknown. During the same period patient was treated with BENADRYL, IBUPROFEN, PREDNISONE, BENICAR, CALCIUM. Patient was hospitalized. Patient recovered.
Myozyme Side Effects Report #5285757-2
Health Professional from UNITED STATES reported Myozyme side effect on Nov 22, 2006. Male patient was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: body temperature increased, chills, tachycardia. Myozyme dosage: 20 MG/KG Q2WKS IV. During the same period patient was treated with ALPHA. Patient recovered.
Myozyme Side Effects Report #5285758-4
Myozyme side effect was reported by a Consumer or non-health professional from UNITED STATES on Nov 27, 2006. Female patient, 44 years of age, weighting 209.4 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: blood pressure increased, heart rate increased, hot flush. Myozyme dosage: 20 MG/KG Q2WKS IV. During the same period patient was treated with ALPHA. Patient recovered.
Myozyme Side Effects Report #5285759-6
Health Professional from UNITED STATES reported Myozyme side effect on Nov 30, 2006. Male patient, 51 years of age, weighting 210.0 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: infusion site extravasation. Myozyme dosage: 20 MG/KG Q2WKS IV. Patient recovered.
Myozyme Side Effects Report #5285760-2
Myozyme side effect was reported by a Health Professional from UNITED STATES on Dec 07, 2006. Female patient, 37 years of age, weighting 112.0 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: chest discomfort, infusion site reaction. Myozyme dosage: 20 MG/KG Q2WKS IV. During the same period patient was treated with TOPROL, CELEBREX, PAXIL. Patient recovered.
Myozyme Side Effects Report #5285761-4
Pharmacist from UNITED STATES reported Myozyme side effect on Dec 12, 2006. Female patient, weighting 12.57 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: nasal flaring, oxygen saturation decreased. Myozyme dosage: 150 MG Q2WKS IV. Patient recovered.
Myozyme Side Effects Report #5285762-6
Myozyme side effect was reported by a Pharmacist from UNITED STATES on Dec 13, 2006. Female patient, 56 years of age, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: infection
. Myozyme dosage: 1500 MG Q2WKS IV. Patient recovered.Myozyme Side Effects Report #5285764-X
Health Professional from UNITED STATES reported Myozyme side effect on Oct 11, 2006. Female patient, 38 years of age, weighting 112.4 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: nausea
. Myozyme dosage: 20 MG/KG Q2WKS IV. During the same period patient was treated with PROZAC, CLONAZEPAM, CLARITIN, AMITRIPTYLINE. Patient recovered.Myozyme Side Effects Report #5285765-1
Myozyme side effect was reported by a Health Professional from UNITED STATES on Oct 11, 2006. Female patient, 38 years of age, weighting 112.4 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: anxiety
, body temperature increased, rash , tinnitus . Myozyme dosage: 20 MG/KG Q2WKS IV. During the same period patient was treated with PROZAC, CLONAZEPAM, CLARITIN, AMITRIPTYLINE. Patient recovered.Myozyme Side Effects Report #5285766-3
Physician from UNITED STATES reported Myozyme side effect on Sept 29, 2006. Male patient, weighting 18.74 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: chills, hyperhidrosis, pallor, tachycardia, tremor. Myozyme dosage: 20 MG/KG Q2WKS IV. During the same period patient was treated with ALPHA, LASIX, SIMETHICONE, ZANTAC, BENADRYL, TYLENOL. Patient recovered.
Myozyme Side Effects Report #5285767-5
Myozyme side effect was reported by a Physician from UNITED STATES on Sept 29, 2006. Male patient was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: chills, cyanosis, dyskinesia, hyperhidrosis, tachycardia. Myozyme dosage: 20 MG/KG Q2WKS IV. During the same period patient was treated with ALPHA, TYLENOL, BENADRYL. Patient recovered.
Myozyme Side Effects Report #5285768-7
Pharmacist from UNITED STATES reported Myozyme side effect on Oct 02, 2006. Male patient, 38 years of age, weighting 137.3 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: feeling hot, flushing, hyperhidrosis, oedema peripheral, palmar erythema, pruritus, skin tightness, urticaria. Myozyme dosage: 20 MG/KG Q2WKS IV. During the same period patient was treated with TYLENOL. Patient recovered.
Myozyme Side Effects Report #5285769-9
Myozyme side effect was reported by a Physician from UNITED STATES on Sept 29, 2006. Male patient, 58 years of age, weighting 259.0 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: headache
. Myozyme dosage: 20 MG/KG Q2WKS IV. Patient recovered.Myozyme Side Effects Report #5285770-5
Health Professional from UNITED STATES reported Myozyme side effect on Oct 10, 2006. Female patient, 45 years of age, weighting 126.3 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: chest discomfort, heart rate increased. Myozyme dosage: 20 MG/KG Q2WKS IV. During the same period patient was treated with NEXIUM, LISINOPRIL. Patient recovered.
Myozyme Side Effects Report #5285771-7
Myozyme side effect was reported by a Health Professional from UNITED STATES on Oct 30, 2006. Female patient, weighting 17.64 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: bradycardia. Myozyme dosage: 20 MG/KG IV. During the same period patient was treated with TYLENOL, BENADRYL. Patient recovered.
Myozyme Side Effects Report #5285772-9
Health Professional from UNITED STATES reported Myozyme side effect on Nov 01, 2006. Male patient, 21 years of age, weighting 73.19 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: blood pressure decreased, heart rate decreased. Myozyme dosage: 20 MG/KG Q2WKS IV. During the same period patient was treated with VITAMIN. Patient recovered.
Myozyme Side Effects Report #5285773-0
Myozyme side effect was reported by a Physician from UNITED STATES on Oct 31, 2006. Female patient, weighting 16.53 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: flushing, rash macular, urticaria. Myozyme dosage: 20 MG/KG Q2WKS IV. During the same period patient was treated with ALPHA. Patient recovered.
Myozyme Side Effects Report #5285774-2
Physician from UNITED STATES reported Myozyme side effect on Nov 03, 2006. Female patient, 35 years of age, weighting 121.9 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: bronchitis
. Myozyme dosage: 20 MG/KG Q2WKS IV. Patient recovered.Myozyme Side Effects Report #5285775-4
Myozyme side effect was reported by a Physician from UNITED STATES on Nov 07, 2006. Male patient, 55 years of age, weighting 216.4 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: tinea pedis, urticaria. Myozyme dosage: 1860 MG Q2WKS IV. During the same period patient was treated with ECOTRIN. Patient recovered.
Myozyme Side Effects Report #5285776-6
Physician from UNITED STATES reported Myozyme side effect on Nov 07, 2006. Male patient, 55 years of age, weighting 216.0 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: angioedema, urticaria. Myozyme dosage: 1860 MG Q2WKS IV. During the same period patient was treated with LAMISIL, ECOTRIN. Patient recovered.
Myozyme Side Effects Report #5285777-8
Myozyme side effect was reported by a Physician from UNITED STATES on Nov 07, 2006. Male patient, 28 years of age, weighting 95.68 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: chest discomfort, dyspnoea, nausea
. Myozyme dosage: 20 MG/KG Q2WKS IV. Patient recovered.Myozyme Side Effects Report #5285778-X
Health Professional from UNITED STATES reported Myozyme side effect on Nov 21, 2006. Female patient, 60 years of age, weighting 160.9 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: dysphagia, meniscus lesion, oedema peripheral, synovial cyst. Myozyme dosage: unknown. Patient recovered.
Myozyme Side Effects Report #5229670-5
Myozyme side effect was reported by a Physician from TAIWAN, PROVINCE OF CHINA on Jan 18, 2007. Male patient, child 3 years of age, weighting 32.85 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, arthropod bite, aspartate aminotransferase increased, blood lactate dehydrogenase increased, bone density decreased, decubitus ulcer, dry gangrene, eczema
. Myozyme dosage: 20 MG/KG Q2WKS IV. During the same period patient was treated with ALPHA, AMBROXOL, CARDIOLOL, ISOMIL, BIOCAL. Patient was hospitalized and became disabled. Patient recovered.Myozyme Side Effects Report #5229673-0
Physician from GREECE reported Myozyme side effect on Jan 18, 2007. Female patient, weighting 17.64 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: abdominal infection, alanine aminotransferase increased, aspartate aminotransferase increased, blood immunoglobulin g increased, cardio-respiratory arrest, cardiopulmonary failure, cyanosis, diarrhoea, dilatation ventricular. Myozyme dosage: 20 MG/KG QWK IV. During the same period patient was treated with ALPHA, HCL THIAZIDE, SPIRONOLACTONE, DIGITALIS, ENALAPRIL MALEATE. Patient was hospitalized. Patient died on 12/29/2006.
Myozyme Side Effects Report #5233304-3
Myozyme side effect was reported by a Physician from UNITED STATES on Jan 26, 2007. Male patient, weighting 12.13 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: asthenia, blood creatine phosphokinase increased, blood immunoglobulin g increased, c-reactive protein increased, candidiasis, central line infection, echocardiogram abnormal, enterococcal infection, eyelid function disorder. Myozyme dosage: 20 MG/KG Q2WKS IV. During the same period patient was treated with BUDESONIDE, XOPENEX, LANSOPRAZOLE, DIGOXIN, PROPRANOLOL, AMIODARONE, BENADRYL. Patient was hospitalized. Patient recovered.
Myozyme Side Effects Report #5233627-8
Physician from HUNGARY reported Myozyme side effect on Jan 24, 2007. Female patient, 43 years of age, weighting 114.6 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: abdominal distension, anaphylactic reaction, fall
, fatigue, muscular weakness, poor peripheral circulation. Myozyme dosage: 20 MG/KG Q2WKS IV. During the same period patient was treated with SUPRASTIN, TELFAST, CALCIUM GLUCONATE. Patient recovered.Myozyme Side Effects Report #5233628-X
Myozyme side effect was reported by a Physician from ITALY on Jan 24, 2007. Male patient, 40 years of age, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: pain in extremity, venous occlusion. Myozyme dosage: MG/KG UNK IV. Patient recovered.
Myozyme Side Effects Report #5233630-8
Physician from BRAZIL reported Myozyme side effect on Jan 24, 2007. Male patient, 46 years of age, weighting 165.3 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: respiratory failure. Myozyme dosage: 20 MG/KG Q2WKS IV. Patient died on 01/19/2007.
Myozyme Side Effects Report #5236946-4
Myozyme side effect was reported by a Physician from UNITED STATES on Jan 26, 2007. Male patient, weighting 11.05 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: carbon dioxide increased, cardiomegaly, muscular weakness, pneumonia
, respiratory distress, sleep apnoea syndrome. Myozyme dosage: 130 MG Q2WKS IV. During the same period patient was treated with ALBUTEROL, PROPRANOLOL, ZANTAC. Patient was hospitalized. Patient recovered.Myozyme Side Effects Report #5236949-X
Physician from UNITED STATES reported Myozyme side effect on Jan 26, 2007. Female patient, 37 years of age, weighting 112.0 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: blood immunoglobulin e increased, chest discomfort, chest pain
, dyspnoea, feeling abnormal, infusion related reaction, rash , throat tightness, urticaria. Myozyme dosage: 20 MG/KG Q2WKS IV. During the same period patient was treated with TYLENOL, BENADRYL, TOPROL, CELEBREX, PAXIL. Patient recovered.Myozyme Side Effects Report #5236957-9
Myozyme side effect was reported by a Physician from UNITED STATES on Jan 26, 2007. Female patient, weighting 26.01 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: cardiac failure, international normalised ratio increased, prothrombin time prolonged, respiratory distress, shock, urine output decreased, urticaria. Myozyme dosage: 250 MG Q2WKS IV. During the same period patient was treated with PULMICORT, CAPTOPRIL, CARVEDILOL, DIGOXIN, LASIX. Patient was hospitalized. Patient died on 02/03/2007.
Myozyme Side Effects Report #5237944-7
Physician from NETHERLANDS reported Myozyme side effect on Jan 29, 2007. Female patient, child 8 years of age, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: bradycardia, bronchospasm, cardiac arrest
, erythema, gastroenteritis , infusion related reaction, oedema peripheral, rash , vasoconstriction. Myozyme dosage: 40 MG/KG QWK IV. During the same period patient was treated with ZYRTEC, HYDROCORTISONE. Patient was hospitalized. Patient recovered.Myozyme Side Effects Report #5244241-2
Myozyme side effect was reported by a Physician from GERMANY on Feb 01, 2007. Female patient was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: pneumonia
. Myozyme dosage: 20 MG/KG Q2WKS; IV. During the same period patient was treated with ALPHA. Patient was hospitalized. Patient recovered.Showing 1-50 of 689 Next >